Such neuroinflammatory responses have become a pathological hallmark of AD, driving neurodegeneration through increased inflammatory responses, oxidative stress, synaptic elimination, cellular damage, and amyloid and tau accumulation. The gene discussed is MAPT; the disease is Alzheimer disease.